Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

Felix Stickel, Stephan Buch, Katharina Lau, Henriette Meyer zu Schwabedissen, Thomas Berg, Monika Ridinger, Marcella Rietschel, Clemens Schafmayer, Felix Braun, Holger Hinrichsen, Rainer Günther, Alexander Arlt, Marcus Seeger, Sebastian Müller, Helmut Karl Seitz, Michael Soyka, Markus Lerch, Frank Lammert, Christoph Sarrazin, Ralf Kubitz, Dieter Häussinger, Claus Hellerbrand, Dieter Bröring, Stefan Schreiber, Falk Kiefer, Rainer Spanagel, Karl Mann, Christian Datz, Michael Krawczak, Norbert Wodarz, Henry Völzke, Jochen Hampe – 30 September 2010 – A recent genome‐wide study revealed an assoc

The immunosuppressive pipeline: Meeting unmet needs in liver transplantation

Nazia Selzner, David R. Grant, Itay Shalev, Gary A. Levy – 28 September 2010 – Liver transplantation is now recognized as the treatment of choice for end‐stage liver failure. Its success can be attributed largely to the generation of selective immunosuppressive agents, which have resulted in a dramatic reduction in the incidence of acute rejection and improvements in the short‐ and long‐term outcomes of patients.

Reply

Doris Wagner, Daniela Kniepeiss, Florian Iberer, Astrid Fahrleitner‐Pammer, Peter Kornprat, Karlheinz Tscheliessnigg – 28 September 2010

Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue‐specific biomatrix scaffolds

Yunfang Wang, Cai‐Bin Cui, Mitsuo Yamauchi, Patricia Miguez, Marsha Roach, Richard Malavarca, M. Joseph Costello, Vincenzo Cardinale, Eliane Wauthier, Claire Barbier, David A. Gerber, Domenico Alvaro, Lola M. Reid – 24 September 2010 – Current protocols for differentiation of stem cells make use of multiple treatments of soluble signals and/or matrix factors and result typically in partial differentiation to mature cells with under‐ or overexpression of adult tissue‐specific genes.

Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia‐inducible factor 1α pre‐mRNA in mice and in vitro

Yoon‐Mi Lee, Ji‐Hong Lim, Haejin Yoon, Yang‐Sook Chun, Jong‐Wan Park – 24 September 2010 – Chaetocin, an antibiotic produced by Chaetomium species fungi, was recently found to have antimyeloma activity. Here we examined whether chaetocin has anticancer activities against solid tumors. Chaetocin inhibited the growth of mouse and human hepatoma grafts in nude mice. Immunohistochemical analyses revealed that chaetocin inhibits hypoxia‐inducible factor‐1α (HIF‐1α) expression and vessel formation in the tumors.

Subscribe to